Document is current
Any future updates will be listed below
-
Authors
Alecki, Célia
Rizwan, Javeria
Le, Phuong https://orcid.org/0000-0003-1836-7145
Jacob-Tomas, Suleima
Comaduran, Mario Fernandez https://orcid.org/0009-0007-4002-5017
Verbrugghe, Morgane
Xu, Jia Ming Stella https://orcid.org/0009-0004-3534-840X
Minotti, Sandra
Lynch, James https://orcid.org/0000-0002-5491-3804
Biswas, Jeetayu https://orcid.org/0000-0002-1163-539X
Wu, Tad https://orcid.org/0009-0000-0682-2484
Durham, Heather D.
Yeo, Gene W.
Vera, Maria https://orcid.org/0000-0003-0845-8633
-
Funding
Funding for this research was provided by:
ALS Society of Canada (2022-ALS Discovery Grant, Hudson Translational Team Grant)
Gouvernement du Canada | Canadian Institutes of Health Research (PJT-186141)
Fonds de Recherche du Québec - Santé (300232)
Schmidt Science Fellows and the Eric and Wendy Schmidt AI in Science Postdoctoral Fellowship
Vanier Canada Graduate Scholarship
Leukemia & Lymphoma Society
U.S. Department of Health & Human Services | National Institutes of Health (MH126719, HG004659, HG011864, HG009889)
- License Information
-
More Information
Article History
Received: 15 August 2024
Accepted: 26 November 2024
First Online: 30 December 2024
Competing interests
: G.W.Y. is a Scientific Advisory Board member of Jumpcode Genomics and a co-founder, Board of Directors, and Scientific Advisory Board member, equity holder, and paid consultant for Locanabio and Eclipse BioInnovations. G.W.Y. is a visiting professor at the National University of Singapore. G.W.Y.’s interests have been reviewed and approved by the University of California, San Diego in accordance with its conflict-of-interest policies. The remaining authors declare no competing interests.
